Expression and significance of transforming growth factor-β receptor type ii and DPC4/Smad4 in non-small cell lung cancer

Experimental and Therapeutic Medicine

Volumn 9, Issue 1, 2015, Pages 227-231

  Chen, Hong ^a   Wang, Jing Wei ^b   Liu, Li Xin ^b   Yan, Ji Dong ^b   Ren, Shu Hua ^b   Li, Yan ^b   Lu, Zheng ^b  

^a Departments of Radiotherapy and Chemotherapy   (China)

^b Tangshan Gongren Hospital   (China)

Author keywords

DPC4 Smad4; Non small cell lung cancer; Transforming growth factor receptor type II

Indexed keywords

BETA ACTIN; COMPLEMENTARY DNA; MESSENGER RNA; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ADULT; AGAR GEL ELECTROPHORESIS; AGED; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG LOBECTOMY; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

EID: 84919451569     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.2065     Document Type: Article

References (20)

1. Ginsberg RJ, Vokes EE and Raben A: Non-small cell lung cancer. In: Cancer Principles and Practice of Oncology. DeVita VT Jr, Hellman S and Rosenberg SA (eds). 5th edition. Lippincott-Raven Publishers, Philadelphia, PA, pp858-911, 1997.
2. Wrana JL, Attisano L, Weiser R, Ventura F and Massagué J: Mechanism of activation of the TGF-beta receptor. Nature 370: 341-347, 1994.
3. Moustakas A, Souchelnytskyi S and Heldin CH: Smad regulation in TGF-beta signal transduction. J Cell Sci 114: 4359-4369, 2001.
4. Hahn SA, Schutte M, Hoque AT, et al: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353, 1996.
5. Dumont N, Bakin AV and Arteaga CL: Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells. J Biol Chem 278: 3275-3285, 2003.
6. Takanami I, Tanaka F, Hashizume T and Kodaira S: Roles of the transforming growth factor beta 1 and its type I and II receptors in the development of a pulmonary adenocarcinoma: results of an immunohistochemical study. J Surg Oncol 64: 262-267, 1997.
7. UICC. International Union Against Cancer. TNM Classification of Malignant Tumours. Sixth edition. Wiley-Liss, New York, NY, 2002.
8. Ke Z, Zhang X, Ma L and Wang L: Expression of DPC4/Smad4 in non-small-cell lung carcinoma and its relationship with angiogenesis. Neoplasma 55: 323-329, 2008.
9. Knaus PI, Lindemann D, DeCoteau JF, et al: A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol Cell Biol 16: 3480-3489, 1996.
10. Kim IY, Ahn HJ, Lang S, et al: Loss of expression of transforming growth factor-beta receptors is associated with poor prognosis in prostate cancer patients. Clin Cancer Res 4: 1625-1630, 1998.
11. Tokunaga H, Lee DH, Kim IY, Wheeler TM and Lerner SP: Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients. Clin Cancer Res 5: 2520-2525, 1999.
12. Park K, Kim SJ, Bang YJ, Park JG, Kim NK, Roberts AB and Sporn MB: Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta. Proc Natl Acad Sci USA 91: 8772-8776, 1994.
13. Kim WS, Park C, Jung YS, et al: Reduced transforming growth factor-beta type II receptor (TGF-beta RII) expression in adenocarcinoma of the lung. Anticancer Res 19: 301-306, 1999.
14. Kang Y, Prentice MA, Mariano JM, et al: Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis. Exp Lung Res 26: 685-707, 2000.
15. Wilentz RE, Iacobuzio-Donahue CA, Argani P, et al: Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 60: 2002-2006, 2000.
16. Wilentz RE, Su GH, Dai JL, et al: Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: a new marker of DPC4 inactivation. Am J Pathol l56: 37-43, 2000.
17. de Caestecker MP, Piek E and Roberts AB: Role of transforming growth factor-beta signaling in cancer. J Natl Cancer Inst 92: 1388-1402, 2000.
18. Garrigue-Antar L, Muñoz-Antonia T, Antonia SJ, Gesmonde J, Vellucci VF and Reiss M: Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells. Cancer Res 55: 3982-3987, 1995.
19. Markowitz S, Wang J, Myeroff L, et al: Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338, 1995.
20. Derynck R, Akhurst RJ and Balmain A: TGF-beta signalling in tumor suppression and cancer progression. Nat Genet 29: 117-129, 2001.